"Since inception, the Company has financed cash flow requirements through the issuance of common stock and the exercise warrants and loans. As of June 30, 2014, the Company had $1,402 in cash and cash equivalents. Since June 30, 2014 the Company has raised approximately $1,900 thru the sale of common stock and call of warrants. The Company still has an additional $18,000 of equity capital available under the financing facility with Lincoln Park Capital Fund LLC, and an additional $700 from the anticipated call of warrants. Based upon the cash used for operations for the 6 months ended June 30, 2014 the Company would have sufficient liquidity for approximately 2 years."
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links